<DOC>
	<DOCNO>NCT00728676</DOCNO>
	<brief_summary>To validate outcome measure tolerability Kuvan treatment improvement behavioral symptom 10 select adult Phenylketonuria ( PKU ) without mental retardation .</brief_summary>
	<brief_title>Study Evaluate Effects Kuvan Individuals With Phenylketonuria ( PKU ) With Maladaptive Behaviors</brief_title>
	<detailed_description />
	<mesh_term>Phenylketonurias</mesh_term>
	<criteria>Biochemical confirmation PKU , Measurable maladaptive behavior baseline , Signed informed consent , Not pregnant lactating , Females birth control applicable , Willing comply . Subjects care provider unreliable , use investigational product within 30 day prior enrollment , Pregnant lactating , Concurrent disease condition would interfere study participation safety , ie multiple psychotropic med , condition PI render subject high risk , drug inhibit folate synthesis , Concurrent use levodopa .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>PKU ,</keyword>
	<keyword>Phe ,</keyword>
	<keyword>PAH ,</keyword>
	<keyword>Kuvan ,</keyword>
	<keyword>Trp ,</keyword>
	<keyword>Tyr</keyword>
</DOC>